This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

West Pharmaceutical Services To Share Insights And Showcase Solutions For Drug Delivery, Safety And Efficacy At PDA Conference And AAPS Annual Meeting

LIONVILLE, Pa., Oct. 11, 2012 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative system and component solutions for injectable drug administration, today announced that company representatives will be speaking in several educational sessions and showcasing West's innovations at the Parenteral Drug Association's Universe of Pre-filled Syringes & Injection Devices conference in Las Vegas, October 15-17, 2012, booth #303.

(Logo:  http://photos.prnewswire.com/prnh/20120904/NE65950LOGO )

Experts from West will present on a range of topics related to innovations in drug packaging and delivery systems that demonstrate West's commitment to partnering with drug makers to provide drug delivery and packaging solutions that enable safe, effective administration to patients.

West will participate in several sessions at PDA:

  • New Development of Polymer Syringe ( October 16, 3:30 – 4:00 p.m.): Scott Young, Senior Director, Daikyo Crystal Zenith ® (CZ) Technologies, West, will present on the CZ system, filling capacity and lessons learned with Ute Schleyer, Manager, Pharmaceutical Production, Vetter Pharma-Fertigung.
  • Case Studies in Pre-filled Syringe QbD ( October 17, 7:20 – 7:40 a.m.): Tibor Hlobik, Director, Prefillable Syringe Technologies, West, will present on integrating Quality by Design for prefillable syringe components.
  • Human Factors ( October 17, 8:15 – 9:45 a.m.): Graham Reynolds, Vice President, Marketing and Innovation, West, will moderate a session on human factors in combination products.
  • Case Studies in Human Factors ( October 17, 7:20 – 7:40 a.m.): Chris Evans, Director of Innovation, West, will co-present with Ed Geiselhart, Director, Product Development and Planning, Insight Product Development, on developing delivery systems with the end-user and patient journey in mind.

In addition to its educational sessions, West will showcase a range of the company's innovative drug delivery system technology platforms*, including the SelfDose™, the ConfiDose®, the SmartDose® and other delivery systems that meet the dynamic needs of patients and healthcare providers for safe, effective administration. For more information on the location and timing of West's presentations at PDA, please visit the PDA event agenda online here.

West will also exhibit at the American Association of Pharmaceutical Scientists Annual Meeting & Exposition in Chicago, October 14-18, 2012, booth #1741. Product displays will include NovaPure® components for drug packaging and West's systems and devices for mixing, reconstituting and transferring drugs. West will present the following poster:

  • Characterization of Polymer PFSA Insert Needle System: Effect of Product Fill Volume and Solution Viscosity on CCI, BLE and Residual Volume ( October 16, 1:30 – 4:30 p.m.): Lloyd Waxman, Principal Scientist, West Analytical Laboratories.

"This is an exciting time for the pharmaceutical and biotech industries, with increasing development of biologics, more generics coming on the market and growing global demand for innovative drug delivery technology," said Dr. Mike Schafers, Vice President, Global Marketing, Pharmaceutical Packaging Systems, West. "Drug manufacturers are looking for solutions to bring drug products from concept to the patient more efficiently, reliably and safely. West is working side-by-side with drug manufacturers on innovative drug delivery solutions as a key part of providing patients and healthcare professionals with the best therapies possible."

About WestWest works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of their products. Every day, West is leading the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched and growing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Lionville, Pa., West supports its customers from sales, manufacturing, customer support and research and development locations in North and South America, Europe, Asia and Australia. Established in 1923, West's 2011 sales were $1.2 billion, reflecting daily use of approximately 100 million of its components and devices.

Visit West online at http://www.westpharma.com and follow West on Twitter: http://www.twitter.com/WestPharma

SelfDose™, ConfiDose® and SmartDose® and NovaPure® are trademarks or registered trademarks of West Pharmaceutical Services, Inc. and its subsidiaries in the United States and other jurisdictions.

Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd.

Daikyo Crystal Zenith technology is licensed from Daikyo Seiko, Ltd.

*For investigational use only by our pharmaceutical and biotechnology development partners.

West markets the SmartDose, ConfiDose and SelfDose as integrated systems with drug filling and final assembly completed by the pharmaceutical company.

Media Contact: Kristin Villiotte(781) 684-0770 westpharma@schwartzmsl.com

Investor Contact: Michael A. AndersonVice President and Treasurer (610) 594-3345 Michael.Anderson@westpharma.com

SOURCE West Pharmaceutical Services, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,999.34 -31.80 -0.19%
S&P 500 1,984.13 -1.41 -0.07%
NASDAQ 4,518.9020 -48.6960 -1.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs